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Computers are now a significant part of the health landscape. Across the globe computers are 
increasingly a part of the interactions in both primary care and secondary care. The distribution of 
computers however is variable across each jurisdiction, with differing rates across primary and 
secondary care (1).  Computers are now involved in all parts of the clinical interaction. At the 
consultation level, significant clinician time is now spent interacting with the computer - 16% in 
Australian general practice (2) and 25% in emergency departments (3). These figures represent a 
significant time impost on clinicians, but for what benefit.  
In Australian general practice the most common activity is prescribing (4). Computing started out 
as providing ‘electronic prescription pads’ for electronic prescribing (albeit to still produce a paper 
artifact) is the most common activity, closely followed by recalls, referral letter generation, and 
progress notes. The pace of change is such that as these are 2007 figures, the current state will be 
much higher.  
The impact on the clinical interaction is now quite profound. The presence of a computer changes 
the way in which doctors interact with patients (5), and there is a growing body of literature that 
describes the interaction as a triadic relationship (6-8). The computer as an actor in the 
consultation has many consequences. Information is flowing into the consultation in ways it has not 
in the past, allowing instant reference to national and local sources, form government and others 
(9). Information is a source of power and authority, and the computers ability to bring information 
into the interaction in new ways is changing the power balance.  
At the same time, the presence of the information in the system itself is being recognised as an 
important resource, for a variety of uses: research, clinical governance, population health (10). 
Using data from computer systems for these purposes requires the data to be of high quality, and 
in a form that can be manipulated by computers.  
The final element of this equation is to understand the issues behind the adoption of computers 
into clinical workspaces, the better to inform the future developments of computerisation, 
particularly when developing policy in this area. Adoption of computers has been quite variable 
across the globe. In developed countries for instance, some countries (Denmark, Belgium, Israel) 
have high penetration across the sector. Others (US, Canada) have high uptake in hospitals but 
not primary care or in primary care but not hospitals (Australia, UK) (1). Given that the most 
benefits of eHealth are to be found when the entire system is computerised, understanding the 
process of adoption is crucial (11).  
The fellowship 
This travelling fellowship allowed for me to expand he international exposure and collaboration 
involved in work at the local level, and international. Locally, this involves tow main activities. 
Firstly, as Director of Research at the Inner Eastern Melbourne Medicare Local (IEMML) I have 
been involved in the setting up over 5 years of a data collection and management program, 
involving the practice of the division. Using the PDSA cycle, over the time we have been taking 
practice through now multiple iterative cycles of data collection, analysis and feedback. Whilst 
primarily for improved care within the practice, the outcomes from IEMML perspective have been 
firstly improved data quality, and secondly the practices have allowed IEMML to collect and pool 
the data for knowledge creation purposes. We now have over a hundred practices and data on 
over half a million patients.  
The second element of my work is as the principal clinical lead for the national program, the 
Personally Controlled Electronic Health Record. This is a policy/implementation position, where I 
am involved in the design and development of the program, aimed at making an electronic record 
available to every Australian.  
The fellowship involved a visit to Israel, where I presented my PhD work to a national audience 
(including the deputy director of the health ministry for Israel), and exposure to their simulation 
work on computers in the consultation. In Belgium I was exposed to the national program they are 
developing. In the UK I was a visiting research fellow at the University of Surrey, with Professor 
Simon de Lusignan. It was there that the principle work of clinical governance and data quality was 
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done. Finally I attended the Medical Informatics Europe international conference in Oslo, 
participating in a workshop with Professor de Lusignan on study protocols. 
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Data governance and provenance 
THE MANY FACES OF DATA 
Crucial to improving the quality is understanding the interaction of data (a discrete element) and 
the information expressed in the consultation (often called narrative) The flow of information has 
now been commoditised between the patient, the doctor and the computer, and it is the doctor that 
is primarily responsible for translating the patients expressions into a machine readable code. The 
following example shows the progression from patient to code:   
Patient speech: ‘..and I have these feelings, see, these feelings all the time, like, 
like I just want to not be here’. 
‘So you want to be dead’ 
‘no, no, its not like that. its just a darkness. I’d never kill myself, not with the kids. 
But I just, I just can’t lift the fog, it seems to just overwhelm me’ 
Narrative record: feels constantly down, not suicidal 
Structured diagnosis: Depression 
Code: 310496002, the SNOMED-CT code for Moderate Depression.  
According to Purves (7), we have the concept of the ever reducing amount if information present in 
the consultation. From the ‘fabula’ we have a progressive diminution of ‘information’. a reduction 
from the fabula through what is verbally (and otherwise, let us not forget non-verbal 
communication) in the consultation, though that which is recorded in the medical record (and in 
what form) down to the individual, machine readable code.  
 
The Purves Model 
 
However, what is the purpose of the code - but to give meaning to the information, and indeed to in 
some way remain faithful to the fabula, to the patient, as a representative of a population, who 
came seeking care and information. The dichotomy here is that the point of least information from 
a lifeworld point of view, the code, gives the most amount of information from a systems point of 
view. Habermas (12, 13) would describe this as the tension between the lifeworld, the human day 
to day action, and the System.  
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The dichotomy therefore arises because the system requires a singular element, the code, to 
make most benefit. In the above diagram, the top line represents the Purves model, where in fact 
narrative information is lost at each point, form patient speech to finally the code. From a system 
perspective however, the loss of information goes in the reverse direction. The coded diagnosis is 
of most use, and the patient narrative is of least use.  
The next section discusses the significance of the clinical software, the computational engine that 
sites in the middle of the interaction, mediating the lifeworld/system interface.  
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CL INI CAL SOFTW ARE IN CLINI CAL 
GOVERNANCE 
Introduction 
Computerised medical records (CMR) provide a viable mechanism for implementing clinical 
governance (14). Computers are involved in all aspects of the clinical interaction - from 
consulting room to system-level use of large systems that might control entitlement to 
treatment, screening, recall, and on-line booking of services. Typically around 20% of the 
consultation is spent interacting with the computer (15).    
It is important to understand the context within which records are created (16).  Simply 
having a CMR does not guarantee the creation of a complete record usable for clinical 
governance purposes; the interaction with the computer in the consultation is complex and 
evolving (17, 18).  Using a CMR is not a neutral act (18).  There are barriers to using the 
computer and coding systems (19) and interfacing with them constrains what is recorded 
(20, 21). However, the CMR does enable decision support programs to run that can reduce 
errors, (22) and the CMR can improve quality though audit/feedback cycles (23). There are 
issues about the governance of these records and the repositories derived from these data; 
and formal governance structures are often lacking(24).  
Box 1: Scope and role of an information system to support clinical governance 
 
> Definition: A process for maintenance, improvement, monitoring and 
accountability for driving quality of care.   
> Computerised information systems can use routine data, and specially 
captured additional data (e.g. patient questionnaires) to audit quality. 
> Clinical governance makes demands of managers, clinicians and 
information systems: 
> Chief executives: Responsible and accountable for clinical standards within 
their organisation; including mechanism for measuring them. 
> Doctors: Challenges: Loss of  “clinical freedom,” Clinicians are now 
expected to deliver best practice as defined in evidence-based guidelines; 
and participate in clinical audit.   
> Patients’ views of the service and their “experience” of healthcare are an 
important measure of quality.    
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Methods 
BACKGROUND 
The CMR had the allure of being an unrealised tool to support clinical governance; 
measuring quality, conducting clinical audit, and for ensuring safety.   We therefore 
undertook an analysis of CMR systems used in Australia exploring the extent to which the 
CMR supported clinical governance, including to what extent this reflects contextual factors 
that may be unique to the Australian context.   
REALIST EVALUATION 
We carried out a review from a realist perspective.  A realist perspective is useful in 
assessing complex interventions as it aims to develop explanatory analyses of why and how 
these interventions may work in particular settings and contexts.   The realists mantra is: 
“Context (C)” plus causal link with an appropriate “Mechanism (M)” results in an “Outcome 
(O)” – (C+M=O).” Part of the realist perspective is that effects are reported according to the 
three Ws: “What Works, for Whom in What circumstances.”   
In realist evaluations there can sometimes be difficulty in distinguishing context and 
mechanism.  In this analysis we see the CMR system, used at the point of care, as the 
mechanism (M) and the health system – in this case Australian primary care - as the context 
(C) within which this is being deployed.  Our outcome measure (O) was the capability to 
produce clinical governance outputs - evidenced by the ability to monitor the quality of care 
against given criteria and standards.   This combination describes how in the Australian 
context (C), the CMR might contribute as a mechanism (M) to deliver the outcome measure 
(O), clinical governance (C+M=O) (Figure 1).   
 
Figure 1: Overview model of the method to appraise whether in the context of 
Australian primary care the CMR provided a mechanism for driving clinical governance (CG) 
Context.  
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We mapped the primary care context using Lusignan’s 4 level classification (18):  
> Organisation: Practice, Locality, Region, and National drivers/priorities 
> Individual clinician: Their knowledge of, skill in operation and attitudes towards 
CMR use for governance. 
> Clinical task: Usually the one-to-one clinical consultation that may well involve the 
CMR system, creating a triadic clinical relationship.  
> Technology: Features of the technology, which are unique to the particular context.  
MECHANISM   
We used the Donabedian (25) classification of structure and process elements to describe 
three types of mechanism by which CMRs may enable the delivery of improved clinical 
governance: structures, processes of care and review, and processes that impact on 
outcome.  “Structures” included: the physical structures and design features (including 
conventions for room layout, record architecture and linkages).  Processes of care and 
review included software capabilities such as the issuing of prescriptions.   Processes that 
may impact upon on patient outcomes include elements such as the ability of the CMR 
system to detect and block all serious drug interactions.)   We further divided the 
Donabedian categories: each of these sections section had further subheadings to produce 
the detailed tool across the categories, (see table 1).  The CMR structure was divided using 
the OpenEHR model of the four separate components of a CMR system: interface, clinical 
archetypes, coding system and database <www.openehr.org>.  
Outcome 
We used Holzemer’s classification to look at outcomes (26).  We looked at outcomes for the 
client (or patient), for the healthcare provider (which we took at the locality level) and 
interpreted setting as impact at the population or health system level.   
Assessment tool 
We created a new assessment tool (Appendix 1), a bi-axial tool that used our adaptation of 
Donabedian’s taxonomy (Table 1) to look at mechanism, and de Lusignan’s to explore 
context.  The cells of the grid are populated with outcomes related to clinical governance for 
patients/clients, the provider, and the broader population level. In this study the software 
settings were considered to be process elements. For example, a key enabler of clinical 
governance - such as the presence of a unique patient identifier within the system, essential 
for data aggregation – would be listed as a key component of the mechanism provided by 
the CMR.  
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Table 1: Donabedian based assessment of CMR as a mechanism to support clinical 
governance  
Structures  
System Architecture 
(OpenEPR model) 
 
Interface,  
Clinical archetypes  
Database type 
 Coding systems 
Information & Decision Support Drug databases, interactions, clinical 
calculators 
System Linkages Patient registrations, laboratory links, 
Email 
Search Function Across populations, practices, Export 
functions 
Patient access/Control Access to information through web 
portals, etc.  
Attribution 
Processes – care and review  
Quality Markers Data quality, information quality, system 
accreditation 
Billing/Pay for Performance Routine data use 
Parallel billing system 
Supports population level data outputs Small area 
Sentinel networks 
Epidemiology,  
Outcomes (Demonstrated within the 
system)   
 
 Critical incidents / Near misses / 
Confidential reporting  
 Surrogate markers of quality and 
outcomes/Clinical audit 
 True outcome measures  
ASSESSING THE TOP SIX BRANDS AND ONE 
E XAMPLE OF A CMR SYSTEM W ITH A LOW  
USER BASE 
The top six CMR systems measured in terms of user base (27), were evaluated using this 
tool. We also examined a CMR system with a small installation base (and therefore less 
organizational resources within the company) for comparison.  For each system we used 
either software in demonstration mode, or installed software in training mode. The testing 
was done with simulated patient data, and   independently of the software providers, to 
explore how the system might retain clinical data and enable clinical governance activities. 
Box 2: Software packages reviewed 
 
> Medical Director 2 (Health Communication Network, Sydney, NSW)  
> Best Practice (Best Practice Software, Bundaberg, Queensland) 
> Genie (Genie solutions, Brisbane, Queensland) 
> Medtech32 (Medtech Global, Melbourne, Victoria) 
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Maturity framework 
We developed a CMR maturity model, again using the Donabedian classification into 
structures (including IT architecture issues), process and outcomes, using existing 
consensus about CMR maturity (28-30).  At the structural level we looked at the number of 
vendors and their market share, use of standards and interoperability, and the use of unique 
patients identifiers  and clinical coding (e.g. single national coding system) .  The processes 
were graded from passive reporting through to active decision support – again looking at 
individual patient, practice or locality and population levels.  Outcomes data were expressed 
in terms of feedback about quality (Figure 2). 
 
Figure 2: Schema of the maturity framework 
 
The process and potential of the CMR to influence clinical governance outcomes were 
graded into a four-level model (Table 2).   This grading is multi-dimensional:  
(1) Does the CMR play a passive or dependent role, compared to an active or autonomous 
role in delivering clinical governance;  
(2) The level of complexity of the transaction and whether or not it is adaptive;  
(3) The degree of integration with other information systems;  
(4) The physical integration and linkage processes underpinning it.     
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Table 2: CMR and CG maturity model  
Level 1 Level 2  Level 3 Level 4 
Passive process > Interactive  > Autonomous 
Simple  Complex Adaptive systems 
External Adverse 
Event Reporting (no 
use of system) 
Reporting 
involving 
information from 
CMR 
Reporting using the CMR 
as vehicle 
Interactive reporting 
where CMR both 
sends information and 
receives information, 
informing user of risks 
 
Simple Prescribing Prescribing with 
limited functions 
(interaction 
checking) 
“Intelligent” prescribing 
where CMR uses local 
information such as 
guidelines to inform 
prescribing decisions 
‘Autonomous’ 
prescribing where 
system integrates 
internal and external 
information to 
determine optimal 
management 
 
Simple Audit 
Feedback loops 
Audit data 
compared with 
external data to 
assess 
performance 
Audit data pooled and 
used to develop local 
benchmarks as well as 
population health 
activities 
Real-time data 
aggregation and 
assessment to allow 
‘just in time’ 
monitoring of 
population, during 
pandemics, for 
example 
Largely External    
to CMR 
Integrated in 
CMR 
CMR linked to other 
information sources 
Integrated into 
health system 
Distributed database 
Isolated             Linkage   
 Integration  
Interoperable data   
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Results 
CONTEXT 
Organisational  
In Australia primary care is delivered via general practice through around 7000 discrete 
practices. Patients are free to visit any GP of their choice and GPs act as gatekeepers to 
secondary care. Funding is largely fee-for-service underpinned by a national insurance 
scheme, but there are many accessory payments, (31) and other  programs (32).  Standards 
for clinical governance have been introduced by the Royal Australian College of General 
Practitioners (33).    
Practices in Australia have a variety of ownership structures including corporate owners, 
partners, associates and sessional GPs. Some CMR’s enabled varying degrees of control 
according to status within the practice – owner, employee, etc. Programs also allowed for 
different role-based access for nurses and receptionists.  
The individual clinician 
GPs in Australia are trained in the Australian General Practice Training Program 
(www.agpt.com.au). The curriculum for training includes a specific section on E-Health 
focussed on the practical use of computers, but not their applications for CG.  
98% of GPs have a computer on their desk and use them for clinical purposes.  Most GPs 
use their CMR for recall, maintenance of immunization registers, monitoring of population 
health, making clinical notes and/or recording diagnoses using a clinical coding system (4). 
There are some 22+ clinical packages on the market. Over 40% of GPs are involved in 
some sort of audit/quality assurance cycle associated with using their computer data, 
usually mediated by the local Division of General Practice (9). These activities require good 
data and appropriate extraction techniques.   
Technology 
Although doctors use many sources of information in the consultation (34), it is the clinical 
packages that can have the largest impact on the clinical outcomes. In general practice, the 
government has encouraged good data recording through its Practice Incentive Program. 
Practices have received a payment for recording of allergies and the creation of summary 
data in their CMR’s  
We identified four technological issues that compromise clinical governance activities:  
> Different (and local) coding systems make national and international comparison of 
quality more challenging;  
> The absence of standards meant CMR vendors might develop and implement their 
own messaging ‘standard’ for use between variants of their program including use of 
varying flavours of Health level-7 (HL7), with much less scope for quality control and 
the risk of inbuilt errors.   
> Patient access to the record was absent.  Such facilities are not part of the Australian 
landscape yet.  
> Backup facilities were not inbuilt functions of the software, but were integrated into 
general system backups according to accepted guidelines.  
Clinical task 
The assessment tool divided each of the identified activities according to the actor. The   
individual clinician had little influence on the software processes. In comparison with paper 
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records, we felt the CMR disempowered the clinicians – in effect ceding many areas of 
control to the organisation or the technology.  Customisation options were minimal. Some 
programs did not allow individual doctors to change their passwords without going through 
an administrator.  Access controls for all staff were either set by the program or 
customisable by a designated administrator.  
A significant amount of data required to perform key clinical tasks is now provided by third 
parties, who have to be trusted to have proper governance systems.  The responsibility, 
governance and overall control of these sits outside the CMR.  For example, drug 
information was derived from either government sources or from the industry.  Until 2009, 
the most popular general practice software incorporated screen drug advertising.  An audit 
of these advertisements found that 95% were non-compliant with the Medicines Australia 
Code of Conduct, though there was a little evidence that this impacted upon prescribing 
practice (27).  Most programs sourced travel medicine advice from a variety of sources. 
Immunisation schedule data was the one area that used a common, validated source (the 
federal government).  
There are significant gaps and variability between Australian CMR systems in their drug 
interaction checking, though these issues are international (35). Whilst there are standards 
about CMR functionality they largely fail to include how applications should perform in 
clinical environments   especially as the CMR becomes more  ‘active’ in the patient space 
(36).  
Some areas were easy to ascribe to an actor, but others were quite complex. Drug 
Interactions, for instance, required taking an externally provided database, integrating it into 
the program, and then allowing GPs to potentially customise the level of alert setting, and 
then integrate all of that into the consultation. Others such as practice audit required a 
reliable software process that was then dependent on a practice system to make best use of 
the information.  
MECHANISM – THE CMR 
Mechanism structures 
All systems generated a unique identifier for each patient, and all recorded the Medicare 
number (a non-unique number used for the federal insurance scheme). All CMR systems 
utilized a graphical user interface (GUI) and all had standard clinical archetypes such as 
history, examination, past history, social history. All were able to provide a summary view 
although differences in those views were apparent (37) .  All were able to code diagnosis 
and problem list data, although three different coding systems were used: International 
Classification of Primary Care (ICPC), International Classification of Disease version 10 
(ICD-10) and Doctor Command Language (DOCLE).  None used the Systematised 
Nomenclature of Medicine – Clinical Terms (SNOMED-CT), the official Australian standard 
and none required data to be entered in a coded fashion.  All the CMR systems allowed 
attribution of data according to login, or according to source.  Some incoming data (such as 
specialist letters) required manual attribution, whilst for data such as pathology the 
attribution was automatic.   
Every CMR system was able to accept pathology and radiology as atomized data (either 
HL7 or Pathology Interchange Format).  All programs allowed linking of requests with 
received reports. Four packages allowed both generation of electronic documents and 
receipt.  All used proprietary systems to do this, with little ability to work cross platform.  
The CMR systems (in keeping with the genesis of software systems as electronic 
prescribing packages) had comprehensive drug databases.  Most used the database from 
MIMS Australia, otherwise using information from a variety of sources.  Data regarding 
Australia’s Pharmaceutical Benefits Scheme (PBS), which detailed government subsidies for 
most drugs, was sourced from the PBS itself.  All had ability to generate drug interactions, 
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although users were able to set the level of drug interaction alerts and in several systems 
turn them off altogether.  Use and availability of drug calculators (weight/dose calculators or 
warfarin calculators) was extremely variable. All packages had a variety of other external 
information sources available from within the system.  
All CMR systems had immunisation information, many had travel information, and one had 
an extensive library of text based health information resources within the program.  
All programs have search functions built into the system. Most have some inbuilt searches 
(patients over 65, eligible patients without a cervical smear in the last five years) that relate 
to funding initiatives or chronic disease management. The ability to do other searches was 
quite variable and often required significant computer/database knowledge.  
Mechanism process 
Only four of the CMR systems were able to participate in regional data quality activities. 
These activities revolve around the Australian Primary Care Collaboratives program, The 
Practice Health Atlas, and division’s use of the PEN Clinical Audit tool. All these activities 
require the use of an external tool to interrogate the program’s database and generate 
pooled data. One other package had its own tool to perform similar functions. All programs 
were able to generate pay-for performance lists, according to the particular funding initiative. 
No system had inbuilt data quality checks (prescribing insulin without a diagnosis of 
diabetes for example). One system had an ‘in-house’ sentinel/research network ability, no 
other program had such a designated function.  
Outcomes 
Demonstrated outcomes for the patient: 
Most medical records are computerised and widely used for clinical governance activities, 
but these approaches are fragmented (38).  No package dealt effectively with the health 
outcomes, in the sense that they were able to adequately demonstrate improved care from 
within their own processes.  Assessing health outcomes required an interpretive process by 
accessing and comparing external data.  The tool asked for ‘surrogate markers of quality’ 
and ‘outcome measures’, neither of which was particularly well or sufficiently defined to be 
assessed.  However, in the future these features will become of prime importance.  
Outcomes at population level: 
None of the CMR’s was able to deal directly with these issues. However, the ability of the 
systems to provide data to inform activities at this level is increasingly crucial. Divisions of 
general practice are able to use the data for informing practice at a local level (39) but the 
ability for this data source to influence national activities is currently poor.   
Maturity framework 
At the structural level Australian CMR is well developed but there is scope for further 
progress against our maturity framework.  There are probably too many vendors, a lack of 
open standards, as yet no implementation of a standard coding system.   
Australian primary care is largely at level 2, with some systems only supporting level 1 and 
with some systems offering level 3 models.  There was no evidence of level 4 systems. 
Some CMR systems had features which from the international perspective must be a 
developmental blind alley.  The DOCLE coding systems is one of these, it is unlikely to ever 
become part of an interoperable health system. 
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Discussion 
PRINCIPAL F INDINGS 
In the Australian context, at practice and locality level the CMR works well, and is being 
used to facilitate clinical governance activities.  Nearly all practices have systems with 
search functionality that enable participation in clinical audit. However, whilst practices and 
localities are widely engaged in clinical governance processes, this is being done in an 
uncritical way.  In particular there is little attention given to data quality, and no obligation to 
code clinical conditions. 
The record structures are often proprietary and there is a dearth of open architectural 
models; with many mission critical functions happening within a black box. 
Implications of the findings 
Benchmarking standards at a national or international level will be challenging if poor data 
quality and the disparate nature of record systems and system architecture continues.  It is 
not possible to have lossless conversion of data held in one coding system to another.  
Whilst statistical techniques can be used to compensate for missing data, complete data this 
is never the same as having complete data.  Disease registers are much more challenging 
to set up when there is incomplete coded data, and patients with a condition not on a 
disease register are not going to benefit from computerised prompts or recall.  Their 
standard of care may also be lower.  This data quality and use issue will become a major 
problem as more information is shared. 
Comparison with the literature 
The complexity of the clinician-patient-computer interaction is reflected elsewhere in the 
literature. Patient centred care and relationship centred care  have taken hold and been 
shown to affect outcomes.  Computerisation is changing the balance of power in the 
interaction.   
There is no requirement to provide any specific functionality at all, no set of criteria over 
information use, and no standards over usability or even formally recommended testing 
protocols . The ‘Swiss cheese’ model of error (40), highlights how gaps in complex systems 
can result in errors.  Drug interaction checking is an example of this, with interaction 
resources needing to be integrated into the prescribing package and then used by the 
clinician.   
Patient access to their records has become the norm elsewhere (41) and increased 
openness may to help ensure good governance. Australia has aspirations to provide patient 
access through the National “Personally Controlled Electronic Health Record” program1
A comparison with the UK system of CMR driven pay-for-performance suggests there may 
be quality gaps that computer mediated incentives might help close (
.              
42, 43).  
CONCLUSION 
We have developed a framework for evaluating how CMR systems support clinical 
governance in a particular context; and if those involved in it to achieve their goals. By 
applying the tool to several Australian CMRs we have highlighted the issues that exist today, 
but importantly shown a graded way forward, using a simple model and maturity framework.     
The limitations of the process relate to the heterogeneity of the data and their sources and 
the continuing change over time.  CMR system implementation in Australia has enabled 
better clinical governance. Improving systems technical capability and rigorous 
                                               
1 http://www.nehta.gov.au/ehealth-implementation/what-is-a-pcehr 
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standardisation is likely to be associated with more comprehensive assessment of quality 
and outcomes for patients. 
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Appendix 1: Redesigning descriptions of work, protocols, 
and clinical trials documentation for quality improvement 
and research 
This next section describes the work done on developing a structured approach to designing 
and reporting studies involving data extraction form computerised systems to ensure a 
repeatable view of quality is developed.    
INTRODUCTI ON 
Current descriptions of work (DoW) for clinical audit and protocols for research studies have 
changed very little since the 1990s; and rarely systematically appraise the quality of any 
computerised data they include.  The CONSORT (CONsolidated Standards of Reporting 
Trials) statement sets out clear guidance and let to the development of checklists for the 
reporting of trials (44).  This statement has not only influenced the reporting of trial but also 
led to the development of more systematic schema planning and reporting of other kinds of 
studies.  However, CONSORT contains little about computerised data quality.  Audit and 
service evaluation conducted taking data at face value without an understanding the human 
element of clinical coding or research studies not taking into how and where data might be 
recorded in computerised medical records (CMR) risk error. 
Health services have increasingly become computerised and modelling is an important 
aspect in system development.  Generally the computerisation of primary health care has 
led computerisation of secondary care.  Primary care data provides opportunities for clinical 
audit, service evaluation and ensuring that clinical governance standards are achieved, and 
for research (23).  Modelling provides a mechanism for representing actors involved in a 
process; how they interact and how data flows.  Reference models are generic models that 
apply to range of different circumstances. Whist much of the early development of primary 
care computer systems was organic, developed by small groups of practitioners with 
technical support; newer more complex systems are developed as a result of a more formal 
process.  
GENERIC MODELS FOR RESEARCH AND 
RESEARCH NETW ORKS 
Modelling wider influences on an investigation:  We propose modelling the broader 
influences which might be enabler or form barriers to participation in a study using the 
Business Process Modelling Language (BPMN).  We introduced BPML to define business 
requirements, as processes requirements are important as to whether individual 
practitioners or organisations might participate in a study.  For linked research required the 
same individuals to be represented in both linked databases we need to model 
“geographical requirements”  
Research study modelling: Clinical audit and research studies can be represented by high 
level unified modelling language (UML) diagrams. Data flow models: Data flow diagrams 
illustrate data flows associated with a process.  We present high level data flow diagrams for 
research studies. 
Reference models for using routine data to inform about clinical governance 
Paradigm of clinical governance:  Clinicians have a duty to provide a good standard of care, 
following models of good practice based on evidence-based principles (38) 
Reference models for clinical governance – enabled by routinely collected primary care data 
and wider information sources:    
> Specifying and modelling data collection from clinical trials 
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The randomised controlled trial (RCT) is the gold standard investigation: RCTs are the gold 
standard clinical trial for collecting evidence about the effectiveness of an intervention and 
whilst not immune to criticism have stood the test of time.  The clinical report form (CRT) is a 
core component of a clinical trial as it forms a complete record of the study variables.   
> Modelling the research network 
Research networks as enablers of research: Networks have been developed within primary 
care, at regional and national level to supporting the research process.  The primary care 
networks exist to improve the capability and capacity for research in primary care and to 
recruit to trials and other studies (45).  They can also be part of national or regional sentinel 
networks; or part of single vendor linked data collection schemes. The health service in 
England has developed networks further through the creation of comprehensive research 
network infrastructure.    
The business processes and teams needed to enable research:  We primarily model the 
function of the research or quality improvement network using BPML.   The primary 
functions of the network of are to facilitate data oriented quality improvement activities and 
research.  Our model of an effective network is one with a library or UML and DFD 
templates that can be deployed to support a range of activities. Using a three arm study 
involving the influence of either usual practice, guidlelines and computerised prompts, or 
education sessions on the performance of recording of chronic kidney disease (CKD), the 
design process of the study therefore involves us of the business process model given in 
figure x below. The business process model serves to present a complete frame of the 
working model of the study and is the basis to then move to the next two diagrams, UML 
and DFD.  
 
 
 
UML essentially describes the information processing from the researcher perspective in 
terms of information flow, whilst the DFD concentrates on the actual flow of data. UML 
therefore has a focus on elements such as consent, actions taken by the researchers in 
certain circumstances. DFD’s focus on the technical aspects of elements such as data 
warehousing and storage and extraction processes.  
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Data flow diagram 
Often the modeling in a research study is either absent, or only one element will be 
identified. The intention is that by using all three models, the studies will be better designed 
to prevent data and study problems becoming apparent only when data collection is 
complete and analysis has begun. 
 P a g e  | 23 
 
Appendix 2: A comparative analysis of Adoption between 
Israel and Australia 
This article serves to compare the health systems of two countries, Australia and Israel, with 
the object of determining what each can learn from the other, particularly in the context of 
the computerisation of the health care sector, a change that has the potential to be as 
revolutionary as the introduction of the scientific method in the 1700’s. We start from a 
description of each system, and then move to a discussion of the comparative impacts.  
INTRODUCTI ON  
Article 25 of the United Nations Universal Declaration of Human Rights states: 
Everyone has the right to a standard of living adequate for the health and 
well-being of himself and of his family, including … medical care and 
necessary social services. 
Indeed, the provision of health services is a basic function of any society, whether it is 
provided by the state, or citizens by other means. All societies, from the most primitive to the 
current day have all provided some form of healthcare. The existence of doctor, medicine 
man or healer/‘shaman’ predates probably even the other ‘oldest profession’.  Up until the 
last century, individuals arranged their own healthcare. Now, however, the state takes varied 
but ever increasing roles.  How that intervention occurs is the subject of much debate and 
many and varied models, from the ‘all in ‘ model such as the UK’s National Health Service to 
more laissez faire models exemplified by the United States.   
The effects of this are that the state now plays a significant role in the administration and 
innovation of healthcare. The twin arms available to any government: regulation and funding 
are deployed in varying degrees.  The challenge to governments now is the most efficient 
way of funding the delivery of healthcare, in the context of the greatest change to healthcare 
since the introduction of the scientific method, the computerization of the healthcare space. 
Computers first appeared in health in two well recognized areas. Their use in the wider 
world for administration was mirrored in their adoption for patient administration systems. 
Secondly, the increase in computer power and speed meant that techniques such as CT 
scanning became possible.  
Now, however, the computer (and the internet) is an essential and increasing part of the 
healthcare system (1, 46). Whilst the analysis of the costs involved are difficult (47) the 
impacts can be significant (48). Technology affects costs, care and is a ‘disruptive’ influence 
(49).  
Social theory 
Social theory provides a frame to consider the dilemmas inherent in the state involvement of 
healthcare. This dilemma exists in the conflict between treating health as a large scale, 
policy ‘black box’ when in fact it is, even in this technological age, an intensely personal 
activity based on thousands of human to human interactions every day. We cannot separate 
the patient from the context in which they exist, a context includes relationships at work, in 
the family, and in the wider community.  
The writings of Jurgen Habermas give us a framework in which understand the mechanism 
of the interaction of the state with healthcare, using the concepts of System and Lifeworld. 
Lifeworld is a term first used in a phenomenological description of human society(50). 
Lifeworld is the stock of skills, competencies and knowledge that ordinary members of 
society use in order to negotiate their way through every day life, to interact with other 
people and ultimately to create and maintain social relationships (12). Lifeworld contrasts 
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with the system, which Habermas describes as a rules-governed element, usually 
representing either the economy or the state (13).  It is in the many healthcare interactions, 
the consultations that the system interacts with the patient’s lifeworld. In the lifeworld, 
actions are mediated by communicative action. Similarly in system activity, actions are 
mediated by strategic action.  
Habermas describes the tension between communicative action and strategic action. 
Communicative action refers to interactions that are mediated through talk and oriented to 
an agreement that will provide a basis for consensual co-ordination of individually planned 
actions. Strategic action occurs when at least one party aims to produce an effect on others. 
Strategic action is related to success, rather than to understanding, and occurs when one of 
the parties treats the others as though they are an object. Strategic action is action oriented 
towards success (51). This tension is often manifest in the health professional, who must 
engage with the patients lifeworld and the system in order to mediate the outcome. A 
consultation about certification for work purposes, or government funded initiaves 
(immunization, for example) are classic examples of this tension.  
Patients do not interact with the system, they interact with humans  (52). Increasingly 
though, the system is manifest not only though the health professional, but though the 
computer  (53).  The challenge is to understand how best to use computers as purveyors of 
strategic action, without disrupting the lifeworld, in which they also participate.  
CONTEXT OF HEALTH CARE IN AUSTRALIA  
The Australian Health Care system, like any health system, is a complex interaction of many 
moving parts. But also like any other system, the basic unit of health care consists of the 
many, many interactions between providers and patients. Its uniqueness lies in the blending 
of public and private care, and in the varied funding streams. The summary that follows is a 
very brief simplification that includes only the large scale programs.  
Australia spends 9.4% of its GDP on health, 35% of which goes to public hospitals, and 18% 
on private medical services. The federal government funds the majority of heath care 
through taxation. Each taxpayer pays a Medicare levy (currently 1.5% of taxable income) 
that in part goes to fund the outlays for health. Any shortfall is taken up by general taxation 
revenue. From that the federal government funds the state governments to run public 
hospitals in their areas. For primary care there is a national insurance scheme (called 
Medicare), which provides rebates for fee for service care outside the public hospital 
system. Outside this system, patients can take out insurance to pay for private care in a 
parallel private hospital system.  
From the patient’s perspective, they can see any general practitioner (gp) they choose. 
Once there the GP is free to charge whatever fee they choose, and the patient can claim a 
rebate from the government.  The GP can also choose to not charge the patient, but ‘direct 
bill’ the government. For the patient, this is effectively free care. For secondary care, the 
patient (and their gp) have a choice. Patients can be referred to a specialist (and again, any 
specialist) for which the same rules apply (but only if a referral from general practice has 
occurred). Patients with private insurance can then be sent to a private hospital for care. 
Alternatively, any patient can be sent to a public hospital, where all care is free. Virtually all 
tertiary hospitals in Australia are public hospitals.  
Pharmaceuticals 
Two pieces of detail to funding are relevant to the next discussion. In the first instance the 
Australian PBS. Pharmaceuticals in Australia must first go through a regulatory hurdle of the 
Therapeutic Goods Administration, before being made available. Once listed, a drug can 
then be subsidised through the PBS. For most drugs this means pensioners pay the full cost 
of a drug up to a maximum of $6.40, and the general public the cost up to a maximum of 
$29.90. The government then pays for any difference. There are two further categories to 
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this – drugs that must only be prescribed for a specified purpose (SP), and drugs for which 
an authority must be obtained for prescribing.  In all cases the government is able to 
describe the pack sizes and repeats.  
So, for example, a drug such as Diclofenac (voltaren) has over thirty listings including 50mg 
pack of 20, 50mg pack of 60 (with 5 repeats) SP for the management of osteoarthritis, and 
other classifications requiring authority. The listing is updated quarterly with any changes 
(new drugs, new indications and changes to pack sizes, etc).  
General practice funding 
GPs are the cornerstone of medical practice in Australia. GPS represent half of medical 
practitioners and are the enforced gateway to virtually all secondary care. 85% of the 
Australian populace see a GP each year.  In addition to the fee-for service (FFS) funding 
described earlier, there are several ways in which the federal government provides funding 
for general practice, in order to make up for the deficiencies of FFS. This is through Service 
Incentive Payments (SIP: specific item payments for PAP smears, immunizations etc) and 
Practice Incentive Payments (PIP). The latter are not based on episodes of care, but on the 
provision of service, such as practice nurses.  There has always been a specific PIP for the 
provision of information technology. A PIP is payable on a calculation of practice size, paid 
to the practice (not the individual doctor) and requires the practice to meet certain criteria. 
For Information technology this has been for: having a computer system capable of 
generating a prescription, then for the recording of allergies in the CIS, and now is based on 
the avialbility of electronic resources and provision of secure messaging.  
The final piece of the puzzle is the divisions of general practice network. Currently under 
revision, for the past 15 years there have been around 115 organisations spread across the 
country expressly to support general practice in its activities.  In the late 1990’s divisions 
were funded to provide support officers to enable the computerization of general practice, 
and currently the network has a much smaller number of “e-health support officers” to 
improve data management in general practice.   
Use of computers 
Adoption 
Unlike many other jurisdictions, the adoption of computers in Australia has been largely 
organic. The first clinical use of computers was to utilize administration systems for patient 
recalls.  General Practice computerized rapidly in the 1990’s, driven by the increasing 
complexity of the PBS. Grappling with regulations that had tripled in number, the structured, 
regulated nature of the PBS lent itself to computer support. Early programs were described 
as ‘electronic prescription pads’. When about 50% of practices were computerized the 
government introduced both the PIP for ehealth and funded the division support officers.  
This increased the numbers to where they now stand, at over 90%.  
Lacking the obvious driver of a local need, computerization of the hospital sector remained 
low. Multiple attempts to computerize the clinical space failed, and computerized hospitals 
(in terms of widespread use in clinical settings) is less than 10%, but most states are in the 
midst of significant upgrade programs.  
Use 
Consultations in Australia are about 12 to 14 minutes long, with 10% of the time actively 
interacting with the computer (by use of keyboard). 7% of consultations are initially driven by 
the computer (15). Not surprisingly, prescribing is the most common use of the computer, 
followed by receiving of test results.  There is no facility for e-prescribing nor e-ordering at 
this stage. In fact, because general practice computerized in isolation from the other sectors, 
all communications (including certificates, referrals, etc) are still done by paper. After 
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prescribing and lab results, generating referral letters, updating progress notes, recalls and 
audits are the most used (>50%) functions (4). 
Sharing 
Electronic information about patients is largely kept in silos of electronic repositories that in 
effect mirror the paper equivalents; information cannot leave the electronic walls of the 
institution concerned. The largest collection of data about the Australian population resides 
on the disconnected servers in general practices across the country. In order to correct this 
deficit, the federal government is implementing the ‘Personally Controlled Electronic Health 
Record’ (PCEHR – for more details see www.yourhealth.gov.au). The PCEHR is an 
ambitious program to enable the sharing of information. General Practice and other 
providers will create a Shared Health Summary, and documents such as discharge 
summaries, specialist letters and prescribing will be available to both providers and 
consumers via the system. The PCEHR will not directly hold the information, it will be kept in 
either the source system or in a dedicated repository. Only copies will be displayed by the 
system. The PCEHR is due to be deployed on July 1, 2012.   
CONTEXT OF HEALTH CARE IN ISRAEL 
In Israel, since 1995, a national universal health care law ensures coverage for all. Income 
is subject to a health tax of 4.9% and all permanent residents have to be insured in one of 
four competing Health Funds. Care is provided by a combination of primary curative care via 
the health fund, primary preventive care through a mix of government services and the 
health funds, and secondary/tertiary care by a combination of sick fund, government, and 
NGO clinics and hospitals (54). Funding is provided mostly from the government, but the 
private participation healthcare expenditure is on the rise . All citizens are entitled to a 
Uniform Benefits Package, regardless of which organization they are a member of, and 
treatment under this package is funded for all citizens regardless of their financial means . 
Health care indices in Israel are similar to average European ones, with the exception of a 
higher fertility rate . Health care expenditure is 8 % of GNP in 2008 and has remained stable 
at this level for some years. Presently the major problems of the health care system are 
economic sustainability, an inadequate focus on primary care, and a recent physician strike 
that is still somewhat on-going, already claimed to be the longest labor dispute in Israeli 
history.  
Coverage includes medical diagnosis and treatment, preventive medicine, hospitalization 
(general, maternity, psychiatric and chronic), surgery and transplants, preventive dental care 
for children, first aid and transportation to a hospital or clinic, medical services at the 
workplace, treatment for drug abuse and alcoholism, medical equipment and appliances, 
obstetrics and fertility treatment, medication, treatment of chronic diseases and paramedical 
services such as physiotherapy and occupational therapy . Primary Care (PC) is provided by 
the 4 sick funds (HMOs), through a system of community clinics or solo private practice 
(2,6,7).  Over a 1000 Certified Family Physicians and about 2000 GPs are employed as 
Primary Care Physicians ( PCPs) .Licensed physicians can work privately, e.g. for private 
companies providing physicians for night and weekend calls.  Licensed physicians can be 
employed by hospitals as non-qualified specialists.  Most Israeli graduates seek specialty 
training with about 10% selecting Family Medicine. In Israel, a General Practitioner is a 
licensed physician who has no specialty qualification and is working in Primary Care.  A 
vocationally-trained and Board-certified Family Physician (FP) is a licensed physician who 
went through 4 years of vocational training (VT) or residency in North American terms and 
passed the qualifying examinations MCQ at mid-VT and oral at the end.  Some medical 
specialists provide primary care, privately or through HMOs (typically pediatricians, 
gynecologists and internists).  General Practitioners - mainly IMGs and some local 
graduates without specialty training - make up the bulk of GPs in the community. 
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The four nationwide Sick Funds are: Clalit (the largest with about 54% of the population 
belonging to it), Maccabi, Kupat Holim Meuhedet and Leumit. In 2010, there were 25,542 
doctors in Israel - 3.36 doctors for every 1,000 people. But the number of how many of them 
practice is unknown. 
Pharmaceuticals 
Use of Computers 
All healthcare organizations in Israel and especially the Sick Funds heavily invest in IT. 
While computerised administrative systems appeared in the late 70s and early 80s, 
Ambulatory Computerized Patient Record (CPR) systems were first installed in 1991-3 in the 
two major Funds. Clalit’s “Ofek” project was first in world to aggregate healthcare data 
across different providers (with about 4 million citizens, 55% of population covered). A 
national EHR project is in pilot phase.  
Primary Care Physicians (PCP) are employees of the Health Funds.  Hospital physicians are 
either employees of the hospital via the Ministry of Health, or Clalit Health services which is 
the only HMO to run its own hospitals.  This dependency created a situation where it was 
easier for the providers to be more “persuasive” in the introduction and usage of technology.  
Caregiver natural resistance to the changes, was more easily swept aside with arguments 
for the good of the organization were put forward.   There was almost no resistance to the 
deployment of the new technology. Presently 99.9% of PCPs enter medical data 
electronically, and similar figures exist for the rest of the healthcare system. 
E-prescribing is still not possible, but pilot projects of digital signature of prescriptions are 
already deployed and going fully digital is pending.  Funds members portals are available 
where physicians’ appointments; lab and imaging results and some hospital and specialist 
physician reports are available. Call centres that cater to appointments, emergency advice 
exist, with IT based innovations such a video-consultation with a paediatrician becoming 
increasingly available . The IT staff of the largest Fund, Clalit is around 500, and IT budget - 
1.55% of the organizational budget.    
Business Intelligence programs allow for pro-active medicine such as the prevention 
campaign for colon cancer among the above 50s population. The 'Clicks' CPR system is 
well established in Clalit  & Maccabi and is used by all primary care givers, nurses and most 
of the paramedical staff .   While Maccabi use a centralized data warehouse approach, Clalit 
use a Hybrid model known as the Ofek Project. Ofek is a “Virtual clinical data repository”, 
Clinicians can use Ofek to search all digital data on a patient,. The data is not moved from 
the original site, and is not saved in the clinician’s application. Only the new record is saved. 
Response time is claimed to be <5sec avg. “faster than asking for the file” , but in the 
author’s personal experience it is largely dependent on bandwidth , and at times may take 
up to 20 sec. Use of the Ofek has been extended to non-Clalit hospitals,  Sheba and 
Rambam. Through the Ofek Clalit has successfully created a Virtual Healthcare Record 
(VHR) which is reported to be  to first of its kind in the world .  Based on Microsoft 
technology, Ofek unites disparate data from around the Clalit system and provides a single 
view of all hospital, clinic, and lab data. As it is a VHR, many issues of security have been 
resolved as the data viewed is not stored or kept at the viewer.   Access is severely 
controlled by a central system.   32 different roles have been defined by Clalit and each role 
has very specific rights and privileges.  In hospitals for example, nurses can read/write to the 
data of their own ward, and not view data from another ward, while physicians can 
read/write to their own ward data, but only view data from another ward.  Needless to say, a   
“write-once only” log is kept and any exceptions dealt with immediately at the highest levels 
of the Health Fund.   
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Implications 
The challenge is enhancing the exploitation of the CPR capabilities while empowering the 
patient-doctor relationship. The presence of computers will transform medicine in 
unforeseen ways, presenting us with educational and moral challenges.  
In summary, the two health systems differ little in the amount of funding, but have some 
significant differences in the mechanism of distributing that funding. Australia funds its public 
hospital system via direct method involving grants via the commonwealth, whilst Israel uses 
a purchaser/provider model. Israel extends that purchaser/provider model to community 
care, whilst Australia uses an open ended rebate scheme. Australia concentrates on 
medical care via doctors, whereas Israel includes dental, occupational therapy and 
physiotherapy.  
In terms of computerization, Israel pursued a more centralized program, driven by the health 
funds, whereas Australia has pursued varied approach with a mixture of uptake driven by 
need and some centralized incentives. That they have arrived at very similar results is an 
interesting study, especially when looking at the variation at a more micro level.  
If we assume that the adoption of computers is driven by a balance of three elements: need, 
Incentives and support, then a more detailed iunderstanding of the significance is apparent. 
These three elements occupy three points of a triangle. All three interrelate. If the Need is 
strong, then the requirements of incentives and support are low (think adoption of mobile 
phones). If the need is not there, then more incentives and support are needed. The less 
support, the more incentives, and vice versa.   
   
Although the endpoints are similar, the journeys taken to get there have been quite different. 
In primary care Australia has taken a more organic approach, driven by clinical need. In that 
sense the Australian system has responded better to the lifeworld environment of general 
practice. Where there have been gaps identified, the judicious use of incentives and support 
have removed obstructions and allowed adoption to take place. Thus incentives to buy 
computers, support through divisions to adopt them.  Now there are incentives to use 
structured data for things such as allergies, in other words to get GPs to use computers in a 
way that benefits the system, not the lifeworld.  
An examination of the differences is also illuminating. Australia, with its less centralised 
system, has allowed for segments of the healthcare system to remain computer naïve. 
Outside of large institutions, the decisions on computerisation are made by individual and 
The adoption triangle 1 
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small groups of clinicians on a case by case basis.  Specialists remain poorly computerised 
and therefore poorly integrated into the system. Israel by a centralized system has a more 
complete system, which allows for better transfer of data within the confines of a health 
program.  
The comparison therefore takes us to the process of matching the strategic needs of the 
system with the communication activities at the human level. Central imposition will not work 
well unless it is matched in that way. Understanding the interplay of needs, incentives and 
support will allow policy makers to develop programs that benefit both the big and little 
picture.  
Fellowship Impact 
Since returning and continuing to work on the elements from the fellowship, there have been 
several impacts 
PAPERS 
Submitted 
The computerised medical record as a tool for clinical governance in Australian primary 
care: Pearce C, de Lusignan S, Phillips C, Hall S, Trevaglia S. ; Submitted to 
International Journal of Medical Informatics.  
In final draft 
A Comparison of Health System and EMR Interactions between Israel and Australia: Pearce 
C, Reis S.  
Conference Workshop 
Redesigning descriptions of work, protocols, and clinical trials documentation for quality 
improvement and research. de Lusignan S, Andreasson A, Pearce C, Ntasioudis A, 
Jones S. Medical Informatics Europe, 13th International Conference, User Centred 
Health Care, Oslo, August 2011 
PROJECT 
Monash and Melbourne East General Practice Data NETwork (MAGNET) – represents a 
research collaboration between IEMML and the Monash University Department of 
General Practice involving research uses of the IEMML data cube.  
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